<s id="wsj_1934.1"> 28
2 	 0 	 NP[nb]/N 	 1 	 drug A
2 	 1 	 N/N 	 1 	 drug new
2 	 10 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 drug has
2 	 13 	 (S[pss]\NP)/PP 	 1 	 drug used <XB>
4 	 3 	 (S[to]\NP)/(S[b]\NP) 	 2 	 prevent to
6 	 4 	 (S[b]\NP)/NP 	 2 	 rejection prevent
6 	 5 	 NP[nb]/N 	 1 	 rejection the
6 	 7 	 (NP\NP)/NP 	 1 	 rejection of
9 	 7 	 (NP\NP)/NP 	 2 	 organs of
9 	 8 	 N/N 	 1 	 organs transplanted
11 	 10 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
13 	 11 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 used been
13 	 12 	 (S\NP)/(S\NP) 	 2 	 used successfully
13 	 19 	 ((S\NP)\(S\NP))/NP 	 2 	 used at
13 	 25 	 ((S\NP)\(S\NP))/PP 	 2 	 used according
14 	 13 	 (S[pss]\NP)/PP 	 2 	 on used
15 	 16 	 ((N/N)/(N/N))\(S[adj]\NP) 	 3 	 more than
17 	 16 	 ((N/N)/(N/N))\(S[adj]\NP) 	 2 	 100 than
18 	 14 	 PP/NP 	 1 	 patients on
18 	 17 	 N/N 	 1 	 patients 100
21 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 University at
21 	 20 	 NP[nb]/N 	 1 	 University the
21 	 22 	 (NP\NP)/NP 	 1 	 University of
23 	 22 	 (NP\NP)/NP 	 2 	 Pittsburgh of
26 	 25 	 ((S\NP)\(S\NP))/PP 	 3 	 to according
27 	 26 	 PP/NP 	 1 	 researchers to
<\s>
<s id="wsj_1934.2"> 29
1 	 0 	 NP[nb]/N 	 1 	 drug The
1 	 3 	 (NP\NP)/(S[dcl]\NP) 	 1 	 drug which
1 	 4 	 (S[dcl]\NP)/PP 	 1 	 drug is <XB>
1 	 11 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 drug has
1 	 14 	 S[pss]\NP 	 1 	 drug approved <XB>
4 	 3 	 (NP\NP)/(S[dcl]\NP) 	 2 	 is which
4 	 5 	 (S\NP)\(S\NP) 	 2 	 is still
6 	 4 	 (S[dcl]\NP)/PP 	 2 	 in is
9 	 6 	 PP/NP 	 1 	 phase in
9 	 7 	 NP[nb]/N 	 1 	 phase the
9 	 8 	 N/N 	 1 	 phase experimental
11 	 12 	 (S\NP)\(S\NP) 	 2 	 has n't
13 	 11 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
14 	 13 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 approved been
14 	 15 	 (S\NP)\(S\NP) 	 2 	 approved yet
14 	 16 	 ((S\NP)\(S\NP))/NP 	 2 	 approved by
18 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 Food by
18 	 17 	 NP[nb]/N 	 1 	 Food the
21 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 Admistration by
21 	 17 	 NP[nb]/N 	 1 	 Admistration the
21 	 20 	 N/N 	 1 	 Admistration Drug
26 	 24 	 NP[nb]/N 	 1 	 effects its
26 	 25 	 N/N 	 1 	 effects long-term
26 	 27 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 effects are
26 	 28 	 S[adj]\NP 	 1 	 effects unknown <XB>
28 	 27 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 unknown are
<\s>
<s id="wsj_1934.3"> 24
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 researchers say
2 	 0 	 S/S 	 1 	 say But
4 	 3 	 NP[nb]/N 	 1 	 drug the
4 	 6 	 (S[pss]\NP)/NP 	 1 	 drug called <XB>
4 	 9 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 drug could
4 	 10 	 (S[b]\NP)/NP 	 1 	 drug revolutionize <XB>
4 	 15 	 (S[ng]\NP)/NP 	 1 	 drug reducing <XB>
4 	 21 	 (S[ng]\NP)/NP 	 1 	 drug lowering <XB>
7 	 6 	 (S[pss]\NP)/NP 	 2 	 FK-506 called
9 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 could say
10 	 9 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 revolutionize could
10 	 14 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 revolutionize by
10 	 20 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 revolutionize by <XU>
13 	 10 	 (S[b]\NP)/NP 	 2 	 field revolutionize
13 	 11 	 NP[nb]/N 	 1 	 field the
13 	 12 	 N/N 	 1 	 field transplantation
15 	 14 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 reducing by
18 	 15 	 (S[ng]\NP)/NP 	 2 	 effects reducing
18 	 16 	 N/N 	 1 	 effects harmful
18 	 17 	 N/N 	 1 	 effects side
21 	 20 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 lowering by
23 	 21 	 (S[ng]\NP)/NP 	 2 	 rates lowering
23 	 22 	 N/N 	 1 	 rates rejection
<\s>
<s id="wsj_1934.4"> 16
0 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Rejection has
0 	 2 	 (S[pt]\NP)/NP 	 1 	 Rejection been <XB>
2 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
2 	 6 	 ((S\NP)\(S\NP))/NP 	 2 	 been in
5 	 2 	 (S[pt]\NP)/NP 	 2 	 obstacle been
5 	 3 	 NP[nb]/N 	 1 	 obstacle the
5 	 4 	 N/N 	 1 	 obstacle major
9 	 8 	 (N/N)/(N/N) 	 2 	 30,000 approximately
11 	 6 	 ((S\NP)\(S\NP))/NP 	 3 	 transplants in
11 	 7 	 NP[nb]/N 	 1 	 transplants the
11 	 9 	 N/N 	 1 	 transplants 30,000
11 	 10 	 N/N 	 1 	 transplants organ
11 	 12 	 S[pss]\NP 	 1 	 transplants performed <XB>
12 	 13 	 (S\NP)\(S\NP) 	 2 	 performed world-wide
12 	 14 	 ((S\NP)\(S\NP))/N 	 2 	 performed each
15 	 14 	 ((S\NP)\(S\NP))/N 	 3 	 year each
<\s>
<s id="wsj_1934.5"> 20
0 	 1 	 ((S[dcl]\NP)/PP)/(S[ng]\NP) 	 1 	 Researchers began
0 	 2 	 (S[ng]\NP)/NP 	 1 	 Researchers using <XB>
1 	 5 	 ((S\NP)\(S\NP))/NP 	 2 	 began in
2 	 1 	 ((S[dcl]\NP)/PP)/(S[ng]\NP) 	 3 	 using began
4 	 2 	 (S[ng]\NP)/NP 	 2 	 drug using
4 	 3 	 NP[nb]/N 	 1 	 drug the
6 	 5 	 ((S\NP)\(S\NP))/NP 	 3 	 February in
7 	 1 	 ((S[dcl]\NP)/PP)/(S[ng]\NP) 	 2 	 on began
8 	 7 	 PP/NP 	 1 	 patients on
8 	 9 	 (NP\NP)/(S[dcl]\NP) 	 1 	 patients who
8 	 10 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 patients had <XB>
8 	 11 	 (S[pt]\NP)/NP 	 1 	 patients received <XB>
10 	 9 	 (NP\NP)/(S[dcl]\NP) 	 2 	 had who
11 	 10 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 received had
19 	 11 	 (S[pt]\NP)/NP 	 2 	 transplants received
19 	 12 	 N/N 	 1 	 transplants kidney
19 	 14 	 N/N 	 1 	 transplants liver
19 	 16 	 N/N 	 1 	 transplants heart
19 	 18 	 N/N 	 1 	 transplants pancreas
<\s>
<s id="wsj_1934.6"> 8
1 	 0 	 N/N 	 1 	 two Only
1 	 2 	 (N\N)/NP 	 1 	 two of
1 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 two have
1 	 7 	 S[pss]\NP 	 1 	 two rejected <XB>
4 	 2 	 (N\N)/NP 	 2 	 transplants of
4 	 3 	 N/N 	 1 	 transplants 111
6 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been have
7 	 6 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 rejected been
<\s>
<s id="wsj_1934.7"> 15
1 	 0 	 NP[nb]/N 	 1 	 drug The
1 	 3 	 S[pss]\NP 	 1 	 drug discovered <XB>
1 	 7 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 drug is
1 	 8 	 (S[pss]\NP)/PP 	 1 	 drug metabolized <XB>
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 discovered in
5 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 1984 in
8 	 7 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 metabolized is
9 	 8 	 (S[pss]\NP)/PP 	 2 	 from metabolized
11 	 9 	 PP/NP 	 1 	 fungus from
11 	 10 	 N/N 	 1 	 fungus soil
11 	 12 	 S[pss]\NP 	 1 	 fungus found <XB>
12 	 13 	 ((S\NP)\(S\NP))/NP 	 2 	 found in
14 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 Japan in
<\s>
<s id="wsj_1934.8"> 20
2 	 0 	 NP[nb]/N 	 1 	 patients The
2 	 1 	 N/N 	 1 	 patients Pittsburgh
2 	 3 	 (S[dcl]\NP)/NP 	 1 	 patients are
6 	 3 	 (S[dcl]\NP)/NP 	 2 	 humans are
6 	 4 	 NP[nb]/N 	 1 	 humans the
6 	 5 	 N/N 	 1 	 humans first
8 	 7 	 (S[to]\NP)/(S[b]\NP) 	 2 	 be to
9 	 8 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 given be
11 	 9 	 (S[pss]\NP)/NP 	 2 	 drug given
11 	 10 	 NP[nb]/N 	 1 	 drug the
11 	 13 	 (NP\NP)/(S[dcl]\NP) 	 1 	 drug which
11 	 14 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 drug is <XB>
11 	 15 	 S[pss]\NP 	 1 	 drug made <XB>
14 	 13 	 (NP\NP)/(S[dcl]\NP) 	 2 	 is which
15 	 14 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 made is
15 	 16 	 ((S\NP)\(S\NP))/NP 	 2 	 made by
19 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 Co by
19 	 17 	 N/N 	 1 	 Co Fujisawa
19 	 18 	 N/N 	 1 	 Co Pharmaceutical
<\s>
<s id="wsj_1934.9"> 34
0 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 We 're
0 	 2 	 S[pt]\NP 	 1 	 We shocked <XB>
1 	 6 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 're because
1 	 13 	 (S[dcl]\S[dcl])/NP 	 1 	 're said
2 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 shocked 're
2 	 3 	 ((S\NP)\(S\NP))/NP 	 2 	 shocked by
4 	 3 	 ((S\NP)\(S\NP))/NP 	 3 	 it by
7 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 it 's
7 	 9 	 S[pt]\NP 	 1 	 it worked <XB>
8 	 6 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 's because
9 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 worked 's
9 	 11 	 (S\NP)\(S\NP) 	 2 	 worked fast
11 	 10 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 fast so
13 	 28 	 (S\S)/NP 	 1 	 said at
13 	 32 	 S\S 	 1 	 said here
13 	 33 	 S\S 	 1 	 said yesterday
17 	 13 	 (S[dcl]\S[dcl])/NP 	 2 	 Starzl said
17 	 14 	 N/N 	 1 	 Starzl Dr.
17 	 15 	 N/N 	 1 	 Starzl Thomas
17 	 16 	 N/N 	 1 	 Starzl E.
19 	 13 	 (S[dcl]\S[dcl])/NP 	 2 	 director said
19 	 20 	 (NP\NP)/NP 	 1 	 director of
22 	 23 	 ((N/N)\(N/N))/NP 	 2 	 University of
24 	 23 	 ((N/N)\(N/N))/NP 	 3 	 Pittsburgh of
26 	 20 	 (NP\NP)/NP 	 2 	 Program of
26 	 21 	 NP[nb]/N 	 1 	 Program the
26 	 22 	 N/N 	 1 	 Program University
26 	 25 	 N/N 	 1 	 Program Transplantation
31 	 28 	 (S\S)/NP 	 2 	 conference at
31 	 29 	 NP[nb]/N 	 1 	 conference a
31 	 30 	 N/N 	 1 	 conference news
<\s>
<s id="wsj_1934.10"> 24
0 	 1 	 ((S[dcl]\NP)/NP)/NP 	 1 	 We consider
1 	 12 	 (S[dcl]\S[dcl])/NP 	 1 	 consider said
2 	 1 	 ((S[dcl]\NP)/NP)/NP 	 3 	 it consider
5 	 1 	 ((S[dcl]\NP)/NP)/NP 	 2 	 drug consider
5 	 3 	 NP[nb]/N 	 1 	 drug a
5 	 4 	 N/N 	 1 	 drug life-saving
5 	 7 	 (NP\NP)/NP 	 1 	 drug like
8 	 7 	 (NP\NP)/NP 	 2 	 one like
8 	 9 	 (NP\NP)/NP 	 1 	 one for
10 	 9 	 (NP\NP)/NP 	 2 	 AIDS for
15 	 12 	 (S[dcl]\S[dcl])/NP 	 2 	 Fung said
15 	 13 	 N/N 	 1 	 Fung Dr.
15 	 14 	 N/N 	 1 	 Fung John
18 	 12 	 (S[dcl]\S[dcl])/NP 	 2 	 immunologist said
18 	 17 	 NP[nb]/N 	 1 	 immunologist an
18 	 19 	 (NP\NP)/NP 	 1 	 immunologist at
21 	 19 	 (NP\NP)/NP 	 2 	 University at
21 	 20 	 NP[nb]/N 	 1 	 University the
21 	 22 	 (NP\NP)/NP 	 1 	 University of
23 	 22 	 (NP\NP)/NP 	 2 	 Pittsburgh of
<\s>
<s id="wsj_1934.11"> 25
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 Researchers say
2 	 3 	 (S[dcl]\NP)/S[dcl] 	 1 	 they believe
3 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 believe say
4 	 5 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 FK-506 is
4 	 9 	 S[adj]\NP 	 1 	 FK-506 effective <XB>
5 	 3 	 (S[dcl]\NP)/S[dcl] 	 2 	 is believe
7 	 6 	 ((S[adj]\NP)/(S[adj]\NP))/((S[adj]\NP)/(S[adj]\NP)) 	 3 	 times 100
9 	 5 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 effective is
9 	 7 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 effective times
9 	 8 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 effective more
9 	 10 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 2 	 effective than
14 	 10 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 3 	 drug than
14 	 11 	 NP[nb]/N 	 1 	 drug the
14 	 12 	 N/N 	 1 	 drug traditional
14 	 13 	 N/N 	 1 	 drug anti-rejection
14 	 18 	 S[pss]\NP 	 1 	 drug made <XB>
16 	 10 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 3 	 cyclosporine than
16 	 18 	 S[pss]\NP 	 1 	 cyclosporine made <XB>
18 	 19 	 ((S\NP)\(S\NP))/NP 	 2 	 made by
24 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 Ltd by
24 	 20 	 N/N 	 1 	 Ltd Swiss
24 	 21 	 N/N 	 1 	 Ltd pharmaceutical
24 	 22 	 N/N 	 1 	 Ltd giant
24 	 23 	 N/N 	 1 	 Ltd Sandoz
<\s>
<s id="wsj_1934.12"> 29
0 	 1 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 They are
0 	 3 	 S[pss]\NP 	 1 	 They encouraged <XB>
1 	 2 	 (S\NP)\(S\NP) 	 2 	 are also
3 	 1 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 encouraged are
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 encouraged by
7 	 6 	 (N/N)/(N/N) 	 2 	 mild relatively
9 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 effects by
9 	 5 	 NP[nb]/N 	 1 	 effects the
9 	 7 	 N/N 	 1 	 effects mild
9 	 8 	 N/N 	 1 	 effects side
9 	 10 	 (NP\NP)/NP 	 1 	 effects of
9 	 13 	 (NP\NP)/PP 	 1 	 effects compared
11 	 10 	 (NP\NP)/NP 	 2 	 FK-506 of
14 	 13 	 (NP\NP)/PP 	 2 	 with compared
15 	 14 	 PP/NP 	 1 	 cyclosporine with
15 	 17 	 (NP\NP)/(S[dcl]\NP) 	 1 	 cyclosporine which
15 	 18 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 cyclosporine can <XB>
15 	 19 	 (S[b]\NP)/NP 	 1 	 cyclosporine cause <XB>
18 	 17 	 (NP\NP)/(S[dcl]\NP) 	 2 	 can which
19 	 18 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 cause can
21 	 19 	 (S[b]\NP)/NP 	 2 	 failure cause
21 	 20 	 N/N 	 1 	 failure renal
23 	 19 	 (S[b]\NP)/NP 	 2 	 morbidity cause
25 	 19 	 (S[b]\NP)/NP 	 2 	 nausea cause
28 	 19 	 (S[b]\NP)/NP 	 2 	 problems cause
28 	 27 	 N/N 	 1 	 problems other
<\s>
<s id="wsj_1934.13"> 20
2 	 0 	 NP[nb]/N 	 1 	 effects The
2 	 1 	 N/N 	 1 	 effects side
2 	 4 	 (NP\NP)/NP 	 1 	 effects of
2 	 7 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 effects have
2 	 8 	 ((S[pt]\NP)/(S[adj]\NP))/NP 	 1 	 effects made <XB>
5 	 4 	 (NP\NP)/NP 	 2 	 cyclosporine of
7 	 19 	 (S[dcl]\S[dcl])\NP 	 1 	 have said
8 	 7 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 made have
10 	 8 	 ((S[pt]\NP)/(S[adj]\NP))/NP 	 3 	 penalty made
10 	 9 	 NP[nb]/N 	 1 	 penalty the
10 	 11 	 (NP\NP)/NP 	 1 	 penalty for
10 	 15 	 S[adj]\NP 	 1 	 penalty high <XB>
13 	 11 	 (NP\NP)/NP 	 2 	 success for
13 	 12 	 NP[nb]/N 	 1 	 success its
15 	 8 	 ((S[pt]\NP)/(S[adj]\NP))/NP 	 2 	 high made
15 	 14 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 high rather
18 	 17 	 N/N 	 1 	 Starzl Dr.
18 	 19 	 (S[dcl]\S[dcl])\NP 	 2 	 Starzl said
<\s>
<s id="wsj_1934.14"> 31
1 	 0 	 N/N 	 1 	 Fung Dr.
1 	 2 	 (S[dcl]\NP)/S[em] 	 1 	 Fung said
3 	 2 	 (S[dcl]\NP)/S[em] 	 2 	 that said
4 	 5 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 FK-506 would
4 	 8 	 S[adj]\NP 	 1 	 FK-506 available <XB>
5 	 3 	 S[em]/S[dcl] 	 1 	 would that
5 	 6 	 (S\NP)\(S\NP) 	 2 	 would not
7 	 5 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be would
7 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 be in
7 	 12 	 ((S\NP)\(S\NP))/NP 	 2 	 be for
8 	 7 	 (S[b]\NP)/(S[adj]\NP) 	 2 	 available be
11 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 market in
11 	 10 	 NP[nb]/N 	 1 	 market the
14 	 13 	 (NP/NP)/(S[asup]\NP) 	 2 	 least at
16 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 year for
16 	 13 	 (NP/NP)/(S[asup]\NP) 	 1 	 year at
16 	 15 	 NP[nb]/N 	 1 	 year a
19 	 2 	 (S[dcl]\NP)/S[em] 	 2 	 that said
23 	 20 	 NP[nb]/N 	 1 	 process the
23 	 21 	 N/N 	 1 	 process FDA
23 	 22 	 N/N 	 1 	 process approval
23 	 25 	 (S[dcl]\NP)/NP 	 1 	 process takes
25 	 19 	 S[em]/S[dcl] 	 1 	 takes that
25 	 24 	 (S\NP)/(S\NP) 	 2 	 takes usually
27 	 25 	 (S[dcl]\NP)/NP 	 2 	 years takes
27 	 26 	 N/N 	 1 	 years three
27 	 28 	 (NP\NP)/NP 	 1 	 years to
30 	 28 	 (NP\NP)/NP 	 2 	 years to
30 	 29 	 N/N 	 1 	 years five
<\s>
<s id="wsj_1934.15"> 25
0 	 1 	 (S[dcl]\NP[thr])/NP 	 1 	 There are
4 	 1 	 (S[dcl]\NP[thr])/NP 	 2 	 plans are
4 	 2 	 NP[nb]/N 	 1 	 plans no
4 	 3 	 N/N 	 1 	 plans firm
4 	 6 	 (S[b]\NP)/NP 	 1 	 plans expand <XB>
6 	 5 	 (S[to]\NP)/(S[b]\NP) 	 2 	 expand to
6 	 10 	 ((S\NP)\(S\NP))/NP 	 2 	 expand beyond
9 	 6 	 (S[b]\NP)/NP 	 2 	 program expand
9 	 7 	 NP[nb]/N 	 1 	 program the
9 	 8 	 N/N 	 1 	 program experimental
12 	 10 	 ((S\NP)\(S\NP))/NP 	 3 	 University beyond
12 	 11 	 NP[nb]/N 	 1 	 University the
12 	 13 	 (NP\NP)/NP 	 1 	 University of
12 	 16 	 ((NP\NP)/(S[dcl]\NP))/N 	 1 	 University whose
14 	 13 	 (NP\NP)/NP 	 2 	 Pittsburgh of
17 	 16 	 ((NP\NP)/(S[dcl]\NP))/N 	 3 	 hospital whose
17 	 18 	 (S[dcl]\NP)/NP 	 1 	 hospital performs <XB>
18 	 16 	 ((NP\NP)/(S[dcl]\NP))/N 	 2 	 performs whose
21 	 18 	 (S[dcl]\NP)/NP 	 2 	 transplants performs
21 	 19 	 NP[nb]/N 	 1 	 transplants the
21 	 20 	 N/N 	 1 	 transplants most
21 	 22 	 (NP\NP)/NP 	 1 	 transplants in
24 	 22 	 (NP\NP)/NP 	 2 	 world in
24 	 23 	 NP[nb]/N 	 1 	 world the
<\s>
<s id="wsj_1934.16"> 49
0 	 1 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Researchers could
0 	 3 	 (S[b]\NP)/NP 	 1 	 Researchers estimate <XB>
1 	 2 	 (S\NP)\(S\NP) 	 2 	 could n't
3 	 1 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 estimate could
5 	 3 	 (S[b]\NP)/NP 	 2 	 cost estimate
5 	 4 	 NP[nb]/N 	 1 	 cost the
5 	 6 	 (NP\NP)/NP 	 1 	 cost of
5 	 9 	 (NP\NP)/S[dcl] 	 1 	 cost when
8 	 6 	 (NP\NP)/NP 	 2 	 drug of
8 	 7 	 NP[nb]/N 	 1 	 drug the
10 	 11 	 (S[dcl]\NP)/NP 	 1 	 it reaches
11 	 9 	 (NP\NP)/S[dcl] 	 2 	 reaches when
13 	 11 	 (S[dcl]\NP)/NP 	 2 	 market reaches
13 	 12 	 NP[nb]/N 	 1 	 market the
16 	 17 	 (S[dcl]\NP)/S[dcl] 	 1 	 they said
18 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 FK-506 will
18 	 20 	 ((S[b]\NP)/(S[to]\NP))/NP 	 1 	 FK-506 enable <XB>
18 	 30 	 (S[b]\NP)/NP 	 1 	 FK-506 reduce <XU>
19 	 17 	 (S[dcl]\NP)/S[dcl] 	 2 	 will said
20 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 enable will
21 	 20 	 ((S[b]\NP)/(S[to]\NP))/NP 	 3 	 patients enable
21 	 23 	 (S[b]\NP)/NP 	 1 	 patients cut <XB>
22 	 20 	 ((S[b]\NP)/(S[to]\NP))/NP 	 2 	 to enable
23 	 22 	 (S[to]\NP)/(S[b]\NP) 	 2 	 cut to
23 	 26 	 ((S\NP)\(S\NP))/NP 	 2 	 cut by
25 	 23 	 (S[b]\NP)/NP 	 2 	 stays cut
25 	 24 	 N/N 	 1 	 stays hospital
28 	 26 	 ((S\NP)\(S\NP))/NP 	 3 	 % by
28 	 27 	 N/N 	 1 	 % 50
30 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 reduce will
32 	 30 	 (S[b]\NP)/NP 	 2 	 number reduce
32 	 31 	 NP[nb]/N 	 1 	 number the
32 	 33 	 (NP\NP)/NP 	 1 	 number of
35 	 33 	 (NP\NP)/NP 	 2 	 tests of
35 	 34 	 N/N 	 1 	 tests blood
35 	 36 	 (S[pss]\NP)/(S[to]\NP) 	 1 	 tests used <XB>
35 	 38 	 (S[b]\NP)/NP 	 1 	 tests monitor <XB>
36 	 46 	 ((S\NP)\(S\NP))/NP 	 2 	 used among
37 	 36 	 (S[pss]\NP)/(S[to]\NP) 	 2 	 to used
38 	 37 	 (S[to]\NP)/(S[b]\NP) 	 2 	 monitor to
40 	 38 	 (S[b]\NP)/NP 	 2 	 dosage monitor
40 	 39 	 NP[nb]/N 	 1 	 dosage the
40 	 41 	 (NP\NP)/NP 	 1 	 dosage of
42 	 41 	 (NP\NP)/NP 	 2 	 cyclosporine of
45 	 41 	 (NP\NP)/NP 	 2 	 drugs of
45 	 44 	 N/N 	 1 	 drugs other
48 	 46 	 ((S\NP)\(S\NP))/NP 	 3 	 recipients among
48 	 47 	 N/N 	 1 	 recipients transplant
<\s>
<s id="wsj_1934.17"> 30
1 	 0 	 N/N 	 1 	 Starzl Dr.
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 Starzl said
4 	 3 	 NP[nb]/N 	 1 	 research the
4 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 research has
4 	 8 	 S[pss]\NP 	 1 	 research financed <XB>
5 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 has said
6 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
6 	 7 	 (S\NP)\(S\NP) 	 2 	 been largely
8 	 6 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 financed been
8 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 financed by
8 	 16 	 ((S\NP)\(S\NP))/NP 	 2 	 financed by <XU>
12 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 Institute by
12 	 10 	 NP[nb]/N 	 1 	 Institute the
12 	 11 	 N/N 	 1 	 Institute National
12 	 13 	 (NP\NP)/NP 	 1 	 Institute of
14 	 13 	 (NP\NP)/NP 	 2 	 Health of
18 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 funds by
18 	 17 	 N/N 	 1 	 funds university
21 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 that said
22 	 23 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Fujisawa did
22 	 25 	 ((S[b]\NP)/NP)/NP 	 1 	 Fujisawa give <XB>
23 	 21 	 S[em]/S[dcl] 	 1 	 did that
23 	 24 	 (S\NP)\(S\NP) 	 2 	 did n't
25 	 23 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 give did
27 	 25 	 ((S[b]\NP)/NP)/NP 	 3 	 hospital give
27 	 26 	 NP[nb]/N 	 1 	 hospital the
29 	 25 	 ((S[b]\NP)/NP)/NP 	 2 	 grants give
29 	 28 	 NP[nb]/N 	 1 	 grants any
<\s>
<s id="wsj_1934.18"> 13
0 	 1 	 (S[dcl]\NP)/S[em] 	 1 	 He said
2 	 1 	 (S[dcl]\NP)/S[em] 	 2 	 that said
5 	 3 	 NP[nb]/N 	 1 	 team the
5 	 4 	 N/N 	 1 	 team research
5 	 6 	 (S[dcl]\NP)/NP 	 1 	 team had
6 	 2 	 S[em]/S[dcl] 	 1 	 had that
9 	 6 	 (S[dcl]\NP)/NP 	 2 	 stake had
9 	 7 	 NP[nb]/N 	 1 	 stake no
9 	 8 	 N/N 	 1 	 stake financial
9 	 10 	 (NP\NP)/NP 	 1 	 stake in
12 	 10 	 (NP\NP)/NP 	 2 	 drug in
12 	 11 	 NP[nb]/N 	 1 	 drug the
<\s>
<s id="wsj_1934.19"> 41
0 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 We 've
0 	 2 	 (S[pt]\NP)/NP 	 1 	 We known <XB>
1 	 30 	 (S[dcl]\S[dcl])\NP 	 1 	 've said
2 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 known 've
2 	 3 	 ((S\NP)\(S\NP))/NP 	 2 	 known for
5 	 3 	 ((S\NP)\(S\NP))/NP 	 3 	 months for
5 	 4 	 N/N 	 1 	 months six
7 	 2 	 (S[pt]\NP)/NP 	 2 	 effect known
7 	 6 	 NP[nb]/N 	 1 	 effect the
7 	 8 	 (NP\NP)/NP 	 1 	 effect of
10 	 8 	 (NP\NP)/NP 	 2 	 drug of
10 	 9 	 NP[nb]/N 	 1 	 drug this
14 	 13 	 NP[nb]/N 	 1 	 advice our
14 	 15 	 (NP\NP)/NP 	 1 	 advice to
14 	 18 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 advice has
14 	 22 	 (S[b]\NP)/NP 	 1 	 advice buy <XB>
17 	 15 	 (NP\NP)/NP 	 2 	 people to
17 	 16 	 NP[nb]/N 	 1 	 people our
18 	 30 	 (S[dcl]\S[dcl])\NP 	 1 	 has said
19 	 18 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
21 	 19 	 (S[pt]\NP)/(S[to]\NP) 	 2 	 to been
21 	 20 	 (S\NP)/(S\NP) 	 2 	 to not
22 	 21 	 (S[to]\NP)/(S[b]\NP) 	 2 	 buy to
24 	 23 	 NP[nb]/N 	 1 	 company the
24 	 25 	 (NP[nb]/N)\NP 	 2 	 company 's
26 	 22 	 (S[b]\NP)/NP 	 2 	 stock buy
26 	 25 	 (NP[nb]/N)\NP 	 1 	 stock 's
29 	 28 	 N/N 	 1 	 Starzl Dr.
29 	 30 	 (S[dcl]\S[dcl])\NP 	 2 	 Starzl said
33 	 32 	 (S[ng]\NP)/S[em] 	 2 	 that adding
34 	 37 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 profiting would
34 	 40 	 S[adj]\NP 	 1 	 profiting ethical <XB>
35 	 34 	 (S[ng]\NP)/PP 	 2 	 from profiting
36 	 35 	 PP/NP 	 1 	 FK-506 from
37 	 33 	 S[em]/S[dcl] 	 1 	 would that
37 	 38 	 (S\NP)\(S\NP) 	 2 	 would n't
39 	 37 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be would
40 	 39 	 (S[b]\NP)/(S[adj]\NP) 	 2 	 ethical be
<\s>
